Seeking Alpha

Cubist Pharmaceuticals (CBST -3.1%) falls after Cantor Fitzgerald says the company's development...

Cubist Pharmaceuticals (CBST -3.1%) falls after Cantor Fitzgerald says the company's development of a competing product indicates it likely isn't preparing to bid for Optimer Pharmaceuticals (OPTR +0.1%). Analyst Irina Rivkind downgraded the stock to Sell Wednesday. (See: Optimer surges on takeover chatter)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector